Imidazo[1,2-A]Pyridine: Potent Biological Activity, SAR and DockingInvestigations (2017-2022)

咪唑吡啶 抗真菌 化学 对接(动物) 吡啶 组合化学 药理学 医学 有机化学 皮肤病科 护理部
作者
Aditya Narayan,Shivkant Patel,Sunil Baile,Surabhi Jain,Smriti Sharma
出处
期刊:Infectious disorders drug targets [Bentham Science Publishers]
卷期号:24 (8): e200324228067-e200324228067 被引量:16
标识
DOI:10.2174/0118715265274067240223040333
摘要

BACKGROUND: Regarding scientific research, Imidazo[1,2-a] pyridine derivatives are constantly being developed due to the scaffold's intriguing chemical structure and varied biological activity. They are distinctive organic nitrogen-bridged heterocyclic compounds that have several uses in medicines, organometallics and natural products. It has become a vital tool for medicinal chemists. METHODS: In order to gather scientific information on Imidazo[1,2-a] pyridines derivative, Google, PubMed, Scopus, Google Scholar, and other databases were searched. In the current study, the medicinal value and therapeutic effect of Imidazo[1,2-a] pyridines were investigated using above mentioned databases. The current study analyzed the detailed pharmacological activities of Imidazo[1,2-a] pyridine analogs through literature from diverse scientific research works. RESULTS: Due to its wide range of biological activities, including antiulcer, anticonvulsant, antiprotozoal, anthelmintic, antiepileptic, antifungal, antibacterial, analgesic, antiviral, anticancer, anti-inflammatory, antituberculosis, and antitumor properties, imidazopyridine is one of the most significant structural skeletons in the field of natural and pharmaceutical products. An imidazopyridine scaffold serves as the basis for a number of therapeutically utilized medications, including zolpidem, alpidem, olprinone, zolimidine, and necopidem. CONCLUSION: This comprehensive study covers the period of the last five years, and it sheds light on the developments and emerging pharmacological actions of Imidazo[1,2-a] pyridines. Additionally, the structure-activity relationship and molecular docking studies are carefully documented throughout the paper, providing medicinal chemists with a clear picture for developing new drugs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1arkspur的应助被草果采纳,获得10
1秒前
2秒前
jiaqi完成签到,获得积分10
2秒前
阳仔完成签到,获得积分10
3秒前
3秒前
chx发布了新的文献求助20
3秒前
llly发布了新的文献求助10
3秒前
4秒前
海波发布了新的文献求助10
5秒前
liu发布了新的文献求助10
5秒前
6秒前
6秒前
9999921完成签到 ,获得积分10
6秒前
田様的应助被田泽和采纳,获得10
6秒前
迩宸完成签到,获得积分10
7秒前
Liusqq完成签到,获得积分10
7秒前
飞快的千万的应助被Railgun采纳,获得10
7秒前
7秒前
8秒前
merry完成签到,获得积分10
9秒前
9秒前
9秒前
赘婿的应助被jiaqi采纳,获得10
9秒前
鱼鱼发布了新的文献求助20
10秒前
思恋欢完成签到,获得积分10
12秒前
田様的应助被yy采纳,获得10
12秒前
阳仔发布了新的文献求助10
12秒前
LC发布了新的文献求助10
12秒前
13秒前
哈基米发布了新的文献求助30
13秒前
希望天下0贩的0的应助被谢奕采纳,获得10
14秒前
yuze发布了新的文献求助10
15秒前
15秒前
jack完成签到,获得积分10
16秒前
田様的应助被冷酷的晓瑶采纳,获得10
18秒前
18秒前
ASCK的应助被lmhhhh采纳,获得30
18秒前
栀子发布了新的文献求助10
19秒前
19秒前
岩下松风完成签到,获得积分10
20秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Energie-Contracting 1500
Klimaschutzrecht durch den Energiesektor im Mehrebenensystem – Ein Rechtsvergleich 1000
Oncology Clinical Trials: Successful Design, Conduct, and Analysis, Second Edition 800
Stochastic Models in Operations Research,Vol. 2 600
Organizational Behavior 510
桑白皮エキスの実験的, 臨床的育毛効果について 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8044611
求助须知:如何正确求助?哪些是违规求助? 9476280
关于积分的说明 21283184
捐赠科研通 7612235
什么是DOI,文献DOI怎么找? 3392031
关于科研通互助平台的介绍 2523628
邀请新用户注册赠送积分活动 2429980